Reckitt Benckiser Group (LON:RKT) Trading Up 1.9% – Here’s What Happened

Shares of Reckitt Benckiser Group plc (LON:RKT) traded up 1.9% during trading on Monday . The stock traded as high as GBX 5,172 ($64.35) and last traded at GBX 5,166 ($64.28). 90,327,430 shares changed hands during mid-day trading, an increase of 757% from the average session volume of 10,544,096 shares. The stock had previously closed at GBX 5,072 ($63.11).

Analyst Ratings Changes

Separately, Berenberg Bank lowered their price target on Reckitt Benckiser Group from GBX 5,200 ($64.70) to GBX 5,177 ($64.41) and set a “hold” rating for the company in a report on Wednesday, October 23rd.

Reckitt Benckiser Group Stock Performance

The company has a market cap of £35.71 billion, a P/E ratio of 2,380.65, a PEG ratio of 1.10 and a beta of 0.09. The stock has a fifty day moving average price of GBX 4,864.56 and a two-hundred day moving average price of GBX 4,638.58. The company has a debt-to-equity ratio of 112.52, a current ratio of 0.69 and a quick ratio of 0.46.

Insider Buying and Selling at Reckitt Benckiser Group

In other news, insider Shannon Eisenhardt sold 1,368 shares of Reckitt Benckiser Group stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of GBX 4,723 ($58.77), for a total value of £64,610.64 ($80,391.49). 0.05% of the stock is owned by corporate insiders.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.